Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.
Department of Ophthalmology, Tianjin Baodi Hospital, Tianjin, China.
Front Endocrinol (Lausanne). 2023 Aug 25;14:1196335. doi: 10.3389/fendo.2023.1196335. eCollection 2023.
We aimed to evaluate the risk factors and develop a prognostic nomogram of long-term low vision after diabetic vitrectomy.
This retrospective study included 186 patients (250 eyes) that underwent primary vitrectomy for proliferative diabetic retinopathy with a minimum follow-up period of one year. Patients were assigned to the training cohort (200 eyes) or validation cohort (50 eyes) at a 4:1 ratio randomly. Based on a cutoff value of 0.3 in best-corrected visual acuity (BCVA) measurement, the training cohort was separated into groups with or without low vision. Univariate and multivariate logistic regression analyses were performed on preoperative systemic and ocular characteristics to develop a risk prediction model and nomogram. The calibration curve and the area under the receiver operating characteristic curves (AUC) were used to evaluate the calibration and discrimination of the model. The nomogram was internally validated using the bootstrapping method, and it was further verified in an external cohort.
Four independent risk factors were selected by stepwise forward regression, including tractional retinal detachment (β=1.443, OR=4.235, P<0.001), symptom duration ≥6 months (β=0.954, OR=2.595, P=0.004), preoperative BCVA measurement (β=0.540, OR=1.716, P=0.033), and hypertension (β=0.645, OR=1.905, P=0.044). AUC values of 0.764 (95% CI: 0.699-0.829) in the training cohort and 0.755 (95% CI: 0.619-0.891) in the validation cohort indicated the good predictive ability of the model.
The prognostic nomogram established in this study is useful for predicting long-term low vision after diabetic vitrectomy.
我们旨在评估糖尿病玻璃体切除术后长期低视力的风险因素,并建立一个预测模型。
本回顾性研究纳入了 186 名(250 只眼)接受过糖尿病性增殖性视网膜病变的初次玻璃体切除术治疗且随访时间至少为一年的患者。患者按 4:1 的比例随机分为训练队列(200 只眼)和验证队列(50 只眼)。基于最佳矫正视力(BCVA)测量值的 0.3 为截断值,将训练队列分为低视力组和非低视力组。对术前全身和眼部特征进行单因素和多因素逻辑回归分析,以建立风险预测模型和列线图。使用校准曲线和接受者操作特征曲线(AUC)下面积来评估模型的校准和区分能力。通过bootstrap 方法对列线图进行内部验证,并在外部队列中进行进一步验证。
通过逐步向前回归选择了四个独立的风险因素,包括牵拉性视网膜脱离(β=1.443,OR=4.235,P<0.001)、症状持续时间≥6 个月(β=0.954,OR=2.595,P=0.004)、术前 BCVA 测量值(β=0.540,OR=1.716,P=0.033)和高血压(β=0.645,OR=1.905,P=0.044)。训练队列的 AUC 值为 0.764(95%CI:0.699-0.829),验证队列的 AUC 值为 0.755(95%CI:0.619-0.891),表明该模型具有良好的预测能力。
本研究建立的预测列线图有助于预测糖尿病玻璃体切除术后的长期低视力。